Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?

Background: Metabolic Syndrome (MS) is related to insulin resistance and to type 2 diabetes mellitus. However, patients with type 1 diabetes mellitus (T1DM) may also develop this condition. Aim: To determine the prevalence of MS in patients with T1DM. Material and methods: Cross sectional study of 5...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Báez,María Soledad, Novik A,Victoria, Alegría G,Felipe, Cardemil M,Felipe, Riveros P,Rodrigo, Bofill Ch,Luis
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2009
Materias:	Diabetes mellitus, type 1 Insulin resistance Metabolic syndrome X
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009000700004
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872009000700004
record_format	dspace
spelling	oai:scielo:S0034-988720090007000042010-04-29Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?Báez,María SoledadNovik A,VictoriaAlegría G,FelipeCardemil M,FelipeRiveros P,RodrigoBofill Ch,Luis Diabetes mellitus, type 1 Insulin resistance Metabolic syndrome X Background: Metabolic Syndrome (MS) is related to insulin resistance and to type 2 diabetes mellitus. However, patients with type 1 diabetes mellitus (T1DM) may also develop this condition. Aim: To determine the prevalence of MS in patients with T1DM. Material and methods: Cross sectional study of 52 patients with T1DM aged 18 to 72 years (27 females) with 5 years or more since their diagnosis of T1DM. MS presence was defined according to the Adult Treatment Panel III criteria. Acanthosis nigricans (AN), waist circumference (WC), daily dose of insulin, glycosylated hemoglobin (HbAlc) and micro albuminuria were evaluated. Results: The prevalence of MS was 25% (13/52). A higher daily dose of insulin was required in patients with MS (p =0.018), with AN (p =0.022) and with obesity (p =0.002). A direct association between WC and the dose of insulin was observed (r =0.51; p <0.0001). No association was observed between MS, time of evolution of T1DM, HbAlc or micro albuminuria. Conclusions: In this group of patients with T1DM there was a high prevalence of MS.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.137 n.7 20092009-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009000700004es10.4067/S0034-98872009000700004
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Diabetes mellitus, type 1 Insulin resistance Metabolic syndrome X
spellingShingle	Diabetes mellitus, type 1 Insulin resistance Metabolic syndrome X Báez,María Soledad Novik A,Victoria Alegría G,Felipe Cardemil M,Felipe Riveros P,Rodrigo Bofill Ch,Luis Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?
description	Background: Metabolic Syndrome (MS) is related to insulin resistance and to type 2 diabetes mellitus. However, patients with type 1 diabetes mellitus (T1DM) may also develop this condition. Aim: To determine the prevalence of MS in patients with T1DM. Material and methods: Cross sectional study of 52 patients with T1DM aged 18 to 72 years (27 females) with 5 years or more since their diagnosis of T1DM. MS presence was defined according to the Adult Treatment Panel III criteria. Acanthosis nigricans (AN), waist circumference (WC), daily dose of insulin, glycosylated hemoglobin (HbAlc) and micro albuminuria were evaluated. Results: The prevalence of MS was 25% (13/52). A higher daily dose of insulin was required in patients with MS (p =0.018), with AN (p =0.022) and with obesity (p =0.002). A direct association between WC and the dose of insulin was observed (r =0.51; p <0.0001). No association was observed between MS, time of evolution of T1DM, HbAlc or micro albuminuria. Conclusions: In this group of patients with T1DM there was a high prevalence of MS.
author	Báez,María Soledad Novik A,Victoria Alegría G,Felipe Cardemil M,Felipe Riveros P,Rodrigo Bofill Ch,Luis
author_facet	Báez,María Soledad Novik A,Victoria Alegría G,Felipe Cardemil M,Felipe Riveros P,Rodrigo Bofill Ch,Luis
author_sort	Báez,María Soledad
title	Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?
title_short	Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?
title_full	Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?
title_fullStr	Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?
title_full_unstemmed	Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?
title_sort	síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿una nueva variedad de diabetes?
publisher	Sociedad Médica de Santiago
publishDate	2009
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009000700004
work_keys_str_mv	AT baezmariasoledad sindromemetabolicoenungrupodepacientesdiabeticostipo1unanuevavariedaddediabetes AT novikavictoria sindromemetabolicoenungrupodepacientesdiabeticostipo1unanuevavariedaddediabetes AT alegriagfelipe sindromemetabolicoenungrupodepacientesdiabeticostipo1unanuevavariedaddediabetes AT cardemilmfelipe sindromemetabolicoenungrupodepacientesdiabeticostipo1unanuevavariedaddediabetes AT riverosprodrigo sindromemetabolicoenungrupodepacientesdiabeticostipo1unanuevavariedaddediabetes AT bofillchluis sindromemetabolicoenungrupodepacientesdiabeticostipo1unanuevavariedaddediabetes
_version_	1718436452192223232

Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes?

Ejemplares similares